Shandong Xinhua Pharmaceutical Company Limited (XIN) — Capital Reinvestment Ratio

Latest as of September 2023: 1.44x

Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Capital Reinvestment Ratio of 1.44x as of September 2023, meaning it reinvests 1% of its operating cash flow (€56.11 Million) in capital expenditures (€80.69 Million). See XIN net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

1.44x
Capex / Operating Cash Flow

Operating Cash Flow

€56.11 Million
EUR

Capital Expenditures

€80.69 Million
EUR

Data as of

Sep 2023
Most recent filing

Shandong Xinhua Pharmaceutical Company Limited Capital Reinvestment Ratio (2013–2025)

This chart tracks Shandong Xinhua Pharmaceutical Company Limited's Capital Reinvestment Ratio across 13 annual periods. Check Shandong Xinhua Pharmaceutical Company L (XIN) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Shandong Xinhua Pharmaceutical Company Limited (2013–2025)

Year-by-year Capital Reinvestment Ratio for Shandong Xinhua Pharmaceutical Company Limited from 2013 to 2025. For live market cap and broader valuation context, see market value of Shandong Xinhua Pharmaceutical Company L.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 0.22x €533.73 Million €115.60 Million ▼ -62.5%
2024 0.58x €367.61 Million €212.42 Million ▼ -52.9%
2023 1.23x €265.28 Million €325.13 Million ▲ +279.7%
2022 0.32x €758.24 Million €244.76 Million ▼ -66.4%
2021 0.96x €259.12 Million €249.23 Million ▲ +44.2%
2020 0.67x €420.19 Million €280.19 Million ▼ -36.6%
2019 1.05x €348.27 Million €366.51 Million ▼ -12.2%
2018 1.20x €323.91 Million €388.44 Million ▲ +79.1%
2017 0.67x €389.97 Million €261.11 Million ▲ +29.6%
2016 0.52x €439.35 Million €227.07 Million ▲ +6.6%
2015 0.48x €348.64 Million €169.09 Million ▼ -35.4%
2014 0.75x €346.34 Million €260.17 Million ▼ -77.1%
2013 3.28x €104.99 Million €344.53 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow